Clinical Trial Update: Oxytocin Trial in Prader-Willi Syndrome [Phase 1]

View source ↗

Summary

This update reports that a Phase 1 oxytocin trial in Prader-Willi syndrome has completed. The sponsor listed is the University of Florida.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: University of Florida | Conditions: Prader Willi Syndrome | Phase 1 | Status: COMPLETED